Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
5
Teradata Corp
TDC
US Stock MarketDetailed Quotes
ORKA Oruka Therapeutics
- 9.950
- -0.630-5.95%
Trading Apr 24 12:25 ET
372.53MMarket Cap-26.18P/E (TTM)
10.880High9.840Low72.57KVolume10.670Open10.580Pre Close759.84KTurnover0.31%Turnover RatioLossP/E (Static)37.44MShares33.00052wk High0.98P/B232.89MFloat Cap5.48552wk Low--Dividend TTM23.41MShs Float40838270.811Historical High--Div YieldTTM9.83%Amplitude5.485Historical Low10.470Avg Price1Lot Size
About Oruka Therapeutics Company
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Company Profile
SymbolORKA
Company NameOruka Therapeutics
Listing DateAug 8, 1997
CEODr. Lawrence Otto Klein, PhD
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
Address855 Oak Grove Avenue,Suite 100
CityMenlo Park
ProvinceCalifornia
CountryUnited States of America
Zip Code94025
Phone1-650-606-7910
Websitehttp://www.orukatx.com
Company Executives
- Name
- Position
- Salary
- Dr. Lawrence Otto Klein, PhD
- Director, President and Chief Executive Officer
- 520.91K
- Dr. Joana Goncalves, M.D.
- Chief Medical Officer
- 317.99K
- Arjun Agarwal
- Senior Vice President, Finance and Treasurer
- --
- Dr. Samarth Kulkarni, PhD
- Chairman of the Board
- 27.74K
- Kristine M. Ball
- Independent Director
- 20.55K
- Peter Harwin
- Independent Director
- 19.18K
- Dr. Carl Dambkowski, M.D.
- Independent Director
- 16.27K
- Dr. Cameron Turtle, D.Phil.
- Independent Director
- 20.38K
- Paul T. Quinlan PhD
- General Counsel and Corporate Secretary
- 310.45K
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
